|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.73 INR | -4.96% |
|
-22.51% | -44.64% |
| 07-10 | Bacil Pharma Limited Announces Board Resignations, Effective July 9, 2026 | CI |
| 05-22 | Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 685M 7.19M 6.25M 5.83M 5.35M 10.09M 10.27M 68.76M 26.93M 342M 27M 26.4M 1.13B | P/E 2024 |
-146x | P/E 2025 | 66.4x |
|---|---|---|---|---|---|
| Enterprise Value | 658M 6.9M 6M 5.6M 5.14M 9.7M 9.87M 66.06M 25.87M 328M 25.94M 25.36M 1.08B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
38.46% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.96% | ||
| 1 week | -22.51% | ||
| Current month | -9.70% | ||
| 1 month | -49.90% | ||
| 3 months | -64.57% | ||
| 6 months | -50.55% | ||
| Current year | -44.64% |
| 1 week | 19.73 |  | 24.19 |
| 1 month | 19.73 | | 41.84 |
| Current year | 19.73 | | 61.8 |
| 1 year | 19.73 | | 61.8 |
| 3 years | 4.68 | | 62.56 |
| 5 years | 3.67 | | 62.56 |
| 10 years | 1.57 | | 62.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2025-07-15 | |
| Corporate Secretary | - | 2025-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2025-07-15 | |
| Director/Board Member | 70 | 1990-08-08 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.96% | -22.51% | -47.50% | +117.29% | 3.13M | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1T | |
| -0.76% | -4.34% | +52.04% | +49.09% | 613B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 433B | |
| +0.29% | -2.99% | +39.96% | +34.65% | 350B | |
| +0.56% | -4.13% | +32.18% | +40.36% | 292B | |
| +2.16% | -9.12% | +5.60% | +7.79% | 239B | |
| +1.87% | -8.20% | -1.63% | -41.99% | 206B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 204B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 163B | |
| Average | -0.12% | -5.74% | +19.68% | +55.92% | 350.05B | |
| Weighted average by Cap. | +0.31% | -4.34% | +35.05% | +71.39% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -590K -6.2K -5.38K -5.03K -4.61K -8.7K -8.85K -59.27K -23.21K -294K -23.27K -22.75K -971K | 4.04M 42.4K 36.85K 34.4K 31.58K 59.55K 60.58K 406K 159K 2.02M 159K 156K 6.65M |
| Net Debt | 570K 5.97K 5.19K 4.85K 4.45K 8.39K 8.54K 57.16K 22.39K 284K 22.44K 21.95K 937K | -26.93M -283K -246K -229K -210K -397K -404K -2.7M -1.06M -13.43M -1.06M -1.04M -44.3M |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | ₹19.73 | -4.96% | 63,257 |
| 26-08-03 | ₹20.76 | -4.99% | 8,062 |
| 26-07-31 | ₹21.85 | -4.96% | 7,526 |
| 26-07-30 | ₹22.99 | -4.96% | 3,995 |
| 26-07-29 | ₹24.19 | -4.99% | 4,676 |
- Stock Market
- Stocks
- BACPHAR6 Stock
Select your edition
All financial news and data tailored to specific country editions
